Immune Complex Stimulation of TNFalpha

TNFα 的免疫复合物刺激

基本信息

  • 批准号:
    7211370
  • 负责人:
  • 金额:
    $ 30.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-04-15 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) is an autoimmune/inflammatory disorder in which multiple susceptibility genes have been identified. The genes implicated in SLE fall into four categories: [1] antigen presentation, [2] immune complex clearance, [3] dysregulated antibody production, and [4] dysregulated T cell function. FcgammaR plays a dominant role in the uptake of immune complexes in SLE patients who are hypocomplementemic. These receptors are widely expressed on hematopoietic cells and mediate inflammatory responses to IgG and IgG-immune complexes in addition to acting as receptors for their clearance. Inflammatory responses include phagocytosis, antibody-dependent cell-mediated cytotoxicity, release of cytokines, and release of reactive oxygen intermediates. Regulation of FcgammaR responses depends upon the balance achieved by signals transduced by activating receptors and signals transduced by inhibitory receptors. Our preliminary data suggest that macrophage responses to immune complexes are highly dependent on maturational status and milieu. We hypothesize that FcgammaR polymorphisms associated with decreased binding result in impaired clearance of immune complexes, particularly in SLE patients with active disease and hypocomplementemia. These circulating immune complexes deposit in end organs and incite an inflammatory response. The precise nature of the response depends critically on the prior experience or exposures of the responding cells, maturational status, and milieu. This sensitivity to environmental cues is probably required by a system that mediates both uptake, in which an inflammatory response is undesirable, and response to infection, in which an inflammatory response is desirable. To investigate the role of FcgammaR in SLE, we will determine the role of FcgammaR polymorphisms in the susceptibility to SLE. In specific aim 2, we will define the signaling pathways important in the responses to immune complexes and transcription factors relevant for the response of the TNFalpha gene to immune complexes. In the third aim, we will define the role of chromatin in the regulation of responses to immune complexes.
描述(申请人提供):系统性红斑狼疮(SLE)是一种自身免疫性/炎症性疾病,已发现多种易感基因。与SLE有关的基因分为四类:[1]抗原呈递,[2]免疫复合物清除,[3]抗体产生失调,[4] T细胞功能失调。Fc γ R在低补体血症的SLE患者的免疫复合物摄取中起主导作用。这些受体在造血细胞上广泛表达,除了作为清除IgG和IgG-免疫复合物的受体外,还介导对IgG和IgG-免疫复合物的炎症反应。炎症反应包括吞噬作用、抗体依赖性细胞介导的细胞毒性、细胞因子的释放和活性氧中间体的释放。Fc γ R应答的调节取决于通过活化受体转导的信号和抑制性受体转导的信号实现的平衡。我们的初步数据表明,巨噬细胞对免疫复合物的反应高度依赖于成熟状态和环境。我们推测FcgammaR多态性与结合减少相关,导致免疫复合物清除受损,特别是在活动性疾病和低补体血症的SLE患者中。这些循环免疫复合物存款在终末器官中并引起炎症反应。反应的确切性质主要取决于反应细胞的先前经历或暴露、成熟状态和环境。这种对环境线索的敏感性可能是介导摄取(其中炎症反应是不希望的)和对感染的反应(其中炎症反应是希望的)的系统所需要的。为了研究Fc γ R在SLE中的作用,我们将确定Fc γ R多态性在SLE易感性中的作用。在具体目标2中,我们将定义在免疫复合物反应中重要的信号通路以及与TNF α基因对免疫复合物反应相关的转录因子。在第三个目标中,我们将定义染色质在调节免疫复合物反应中的作用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Noncoding RNAs and LRRFIP1 regulate TNF expression.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATHLEEN E SULLIVAN其他文献

KATHLEEN E SULLIVAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATHLEEN E SULLIVAN', 18)}}的其他基金

USIDNET: A resource for clinical immunologists
USIDNET:临床免疫学家的资源
  • 批准号:
    10410606
  • 财政年份:
    2022
  • 资助金额:
    $ 30.05万
  • 项目类别:
Non-coding RNA Regulation of TNF Alpha
TNF Alpha 的非编码 RNA 调控
  • 批准号:
    7989625
  • 财政年份:
    2010
  • 资助金额:
    $ 30.05万
  • 项目类别:
Non-coding RNA Regulation of TNF Alpha
TNF Alpha 的非编码 RNA 调控
  • 批准号:
    8070422
  • 财政年份:
    2010
  • 资助金额:
    $ 30.05万
  • 项目类别:
Epigenomics of SLE
SLE的表观基因组学
  • 批准号:
    8126220
  • 财政年份:
    2009
  • 资助金额:
    $ 30.05万
  • 项目类别:
Epigenomics of SLE
SLE的表观基因组学
  • 批准号:
    8521081
  • 财政年份:
    2009
  • 资助金额:
    $ 30.05万
  • 项目类别:
Epigenomics of SLE
SLE的表观基因组学
  • 批准号:
    7934622
  • 财政年份:
    2009
  • 资助金额:
    $ 30.05万
  • 项目类别:
Epigenomics of SLE
SLE的表观基因组学
  • 批准号:
    8318805
  • 财政年份:
    2009
  • 资助金额:
    $ 30.05万
  • 项目类别:
Epigenomics of SLE
SLE的表观基因组学
  • 批准号:
    7725549
  • 财政年份:
    2009
  • 资助金额:
    $ 30.05万
  • 项目类别:
Advancing Careers of Investigators in Primary Immune Disorders
促进原发性免疫疾病研究人员的职业发展
  • 批准号:
    10250421
  • 财政年份:
    2009
  • 资助金额:
    $ 30.05万
  • 项目类别:
Advancing Careers of Investigators in Primary Immune Disorders
促进原发性免疫疾病研究人员的职业发展
  • 批准号:
    10018655
  • 财政年份:
    2009
  • 资助金额:
    $ 30.05万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 30.05万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 30.05万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 30.05万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 30.05万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 30.05万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 30.05万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 30.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 30.05万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 30.05万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 30.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了